Recently，The National Pharmacopoeia Committee issued an announcement，It is planned to revise the national standards of alcohol -phosphoricate and aluminoside adenosine for injection。This standard is applicable to all companies that produce this variety。Display by the State Food and Drug Administration stake betting app(CFDA) data display，Since this year，CFDA has twice to inject the problem of safe use of monosoosicate adenosine for injection。

 

  March this year，CFDA issued a notification to revise the instructions for injection of alcohol adenosine for injection，Added 9 adverse reactions，Special emphasis on children's medication at the same time，At present, there is no system research information for children's application of this product，It is recommended that children weigh the advantages and disadvantages when used。April，The State Food and Drug Administration released the 70th issue of "Pharmaceutical Adverse Reactions Information Report"，Prompt to pay attention to the safety risk of single phosphate analogenosine for injection。

 

  Single phosphate Agly -phosphate is an artificial synthetic adenine nucleoside antiviral drug，Its pharmacological effect is binding to the virus's deoxyrum ribonucleic acid polymerase，Reduce its activity and inhibit DNA synthesis，Clinically for oralitis caused by the treatment of herpes virus infection、Portitis、Encephalitis and Big Cyte Virus Infection。Monitoring results display，Injecting My stake betting appthe number of adverse reactions for aluminoside adenosine for injection in recent years has grown rapidly，More serious adverse reactions are reported more，The phenomenon of superpatient medication is more prominent。

 

  National Pharmaceutical Adverse Reacting Case Report Database The Database in the Database is related to the serious adverse reactions of single -phosphoposylsin adenosine, which accounts for 5.05%of the total number of reports，Reports for adverse reactions under the age of 14 accounted for about 80%。

 

  CFDA information display，Single phosphate gonadinosine (including injection) has 47 batches，For some pharmaceutical companies，The medicine even occupies a large part of its overall sales share。CFDA although it is said to strengthen strict management，but，Not to say that this medicine can no longer be used，Just strengthening the supervision of drugs in terms of safety，Remind clinical medication must pay more attention to safe medicine，and closely observe the patient。Before CFDA ordered the product to be delisted，This product can still be used。

 

  but，For the industry，The biggest reminder for enterprises and drug operators is，The safety of drugs stake online sports bettingis placed in an unprecedented position，Drug safety will be the key to product sales。

 

  And this incident give another reminder for the enterprise，Usage of hypertrophic indications for drugs，If it causes quality and safety problems，Be careful again，Do not for the market，Regardless of product safety，In the future, this pair of products may also be fatal。Take monosacidosidosine for injection as an example，The indication approved in my country is & ldquo; oral inflammation caused by the treatment of herpes virus infection、Portitis、Encephalitis and giant cell virus infection & rdquo;，Monitoring data shows that there is a phenomenon of superpatient drugs in this variety，About 79.98%of the total number of reports，If used for bronchitis、pneumonia、respiratory tract infection、tonsillitis, etc.。

 

  For the pharmaceutical market，The future can really survive in the market，Only really active、Safe and reliable and timely and perfect clinical information feedback products。